E193 E193 (Zonisamide 25 mg)

This pill with imprint "E193 E193" is Orange / Gray, Capsule-shape and has been identified as Zonisamide 25 mg. It is manufactured by Sandoz Pharmaceuticals Inc..

Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zonisamide

Imprint:

E193 E193

Strength:

25 mg

Color:

Orange / Gray

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Carbonic anhydrase inhibitor anticonvulsants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Sandoz Pharmaceuticals Inc.

National Drug Code (NDC):

00185-0193

Inactive Ingredients:

microcrystalline cellulose
ferrosoferric oxide
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
hydrogenated castor oil
sodium lauryl sulfate
titanium dioxide

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.